Lescarden Inc has made its first shipment of Catrix Skin Care products to Derm Medica Pte Ltd of Singapore. Derm Medica has been appointed the authorized distributor for the full line of Catrix Skin Care in Singapore and Malaysia.
William Luther, president of Lescarden commented, "We are very pleased to work with an aggressive, market oriented company like Derm Medica. They have established a reputation among dermatologists, plastic surgeons and skin spas in the region as an innovator through the combination of products and technologies they have introduced in the local marketplace. For Lescarden this new relationship is an important step in our continued development of the Asian market for clinical skin care products and procedures." This announcement follows the recent introduction of Catrix Skin Care into the Philippines at the annual meeting of the Philippine Dermatologic Society in November 2007.
Catrix Skin Care products feature the same biologic material found in the Catrix Wound Dressing, an FDA approved product clinically demonstrated to expedite the healing of chronic skin wounds including pressure ulcers, diabetic ulcers as well as severe burns and surgical incisions. The skin care products are utilized in a clinical practice to reduce inflammation while also helping to expedite healing following professional skin care procedures.
Derm Medica Pte. Ltd is a privately held, marketing and distribution company specializing in clinic-based skin and aesthetic care. Derm Medica offers a portfolio of proven high quality brands to address a growing demand in Singapore and Malaysia.
Lescarden, Inc. is a biotechnology company dedicated to the development and marketing of natural, biologic therapies for the chronic wound care, dermatology and osteoarthritis markets.